LOIS M RAMONDETTA to Cyclin-Dependent Kinase Inhibitor p21
This is a "connection" page, showing publications LOIS M RAMONDETTA has written about Cyclin-Dependent Kinase Inhibitor p21.
Connection Strength
0.085
-
Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer. Clin Cancer Res. 2000 Jan; 6(1):278-84.
Score: 0.039
-
A comparative analysis of Ki-67, p53, and p21WAF1CIP1 expression in tamoxifen associated endometrial carcinomas. Anticancer Res. 1998 Nov-Dec; 18(6B):4661-5.
Score: 0.036
-
Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53. Gynecol Oncol. 2001 Dec; 83(3):543-8.
Score: 0.011